Table 5.
Association studies for PADI4 SNPs and rheumatoid arthritis.
| SNPs | Country RA/HC |
Results | Reference |
|---|---|---|---|
| PADI4_89-105 | Japan (830/736) |
PADI4_92, 94, 95, 97, 99, 100, 101 and 104 (P = 0.0000084–0.00051) |
Suzuki et al. 2003 [9] |
| PADI4_89, 90, 92, 104 | UK (839/481) |
Susceptibility haplotype more frequent in RA patients (32.3 versus 29.6) without significance (P = 0.79) |
Barton et al. 2004 [27] |
| PADI4_92, 96 and 102 | France (100 families) |
No significant associations | Caponi et al. 2005 [28] |
| PADI4_92, 94, 97, 99, 100, 103 and 104 | England (111/111) |
PADI4_100 and 103 (P = 0.03). Increase in mRNA expression of PADI4 in PBM from RA versus C | Harney et al. 2005 [12] |
| PADI4_94, 102 and 104 | Japan (1170/926) |
PADI4_94, 102, and 104 (P = 0.0008–0.010) |
Ikari et al. 2005 [26] |
| PADI4_94 and 104 | Spain (354/498) |
No significant associations | Martinez et al. 2005 [29] |
| PADI4_94 | Sweden and North America | Association with RA (P = 0.02) |
Plenge et al. 2005 [55] |
| PADI4_89, 90, 92 and 104 | Korea (545/392) |
Strong association of RA with susceptibility haplotype (P = 1.0 × 10−4) |
Kang et al. 2006 [47] |
| PADI4_89, 90, 92, 94, 95, 96 and 104 | Germany (102/102) |
PADI4_89, 90, and 94 (P = 0.04) |
Hoppe et al. 2006 [11] |
| PADI4_89 and 90 | France (405/275) |
Association with RA (P = 0.03 and 0.003) |
Gandjbakhch et al. 2009 [48] |
RA: rheumatoid arthritis, HC: healthy controls, and PBM: peripheral blood mononuclear.